Fertility And Pregnancy Rapid Test Kits Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


The global Fertility And Pregnancy Rapid Test Kits Market is estimated to be valued at US$ 1,451.9 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview: 

Pregnancy Rapid Test kits help in early detection of pregnancy in women. They are easy-to-usekits providing quick results within 5-10 minutes without laboratory or medical assistance. 

Market key trends: 

One of the key trends driving growth in the fertility and pregnancy rapid test kits market is increasing demand for home use pregnancy and ovulation prediction test kits. Manufacturers are focusing on making test kits more affordable and convenient for home use without medical supervision. Portable personal fertility monitors that track various fertility signs like cervical mucus, basal body temperature, etc on a mobile app are gaining popularity. The increasing use of digital technology in fertility testing and growing preference for home based testing is fueling market growth. 

Read More Insights @ https://www.coherentmarketinsights.com/market-insight/fertility-and-pregnancy-rapid-test-kits-market-3456

Segment Analysis 

The global fertility and pregnancy rapid test kits market is segmented by product type, procedure, application, end user, and region. Based on product type, the market is classified as pregnancy rapid test kits and fertility rapid test kits. The pregnancy rapid test kits segment currently dominates the market as it is widely used for early detection of pregnancy and is highly affordable. Based on procedure, the market is divided into urine test and blood test. The urine test segment accounts for a major market share due to its non-invasive nature. 

Key Takeaways

The global fertility and pregnancy rapid test kits market size is expected to reach US$ 1,451.9 Mn by 2030, exhibiting a CAGR of 4.5% over the forecast period. The growth can be attributed to the increasing awareness about early detection and monitoring of fertility and pregnancy. 

Regional analysis shows that North America dominates the global market and is expected to continue its dominance due to the presence of major players, high healthcare expenditure, and growing technological advancements in fertility and pregnancy rapid test kits in the region. Asia Pacific is projected to be the fastest-growing region owing to the increasing healthcare expenditure and rising focus on fertility treatment in countries like China and India.

Key players operating in the fertility and pregnancy rapid test kits market are SPD Swiss Precision Diagnostic GmbH, DCC Plc., Procter & Gamble, Abbott Laboratories, Alere Inc., Quidel Corporation, bioMérieux SA, Church & Dwight Co., Inc., Prestige Brands Holdings, Inc., and Geratherm Medical AG. Major players are focused on new product launches, strategic partnerships, and regional expansion to strengthen their market position.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

-
Image
A breast pump is a mechanical tool used by breastfeeding women to suction-extract their breast milk, which they then use to feed their newborn children. Both manually and electrically driven breast pumping equipment is available. Breast pumps are advantageous for working women, women with shorter gestational periods, and women who give birth to multiples since they are unable to simultaneously breastfeed all of the babies, therefore they prefer a breast pump. Breast pumps aid in meeting the nutritional needs of babies of working mothers who do not want to sacrifice their development and growth since they are not constantly present with their infants. Business Dynamics Launches of breast pumps by leading industry players are anticipated to fuel the market's expansion throughout the forecast period. For instance, Sonata, the first smart breast pump to give hospital-level performance in a personal use breast pump, was introduced by Madela, Inc. in November 2016. This breast pump conn...
Read more

Angioedema Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2024 To 2031

-
Image
Introduction: Angioedema, a condition characterized by rapid swelling of deeper layers of the skin and mucous membranes, poses a significant health concern for affected individuals. The Angioedema Treatment Market has been witnessing notable advancements, providing a ray of hope for patients grappling with this often unpredictable and potentially life-threatening condition. Market Dynamics: The Angioedema Treatment Market has experienced a paradigm shift in recent years, driven by increased awareness, improved diagnostic capabilities, and a surge in research and development efforts. Angioedema can be hereditary or acquired, and the market is witnessing a growing prevalence of both forms, necessitating a diversified approach to treatment options. Treatment Modalities: Therapeutic approaches to Angioedema have evolved, offering a range of options for patients. Antihistamines and corticosteroids are commonly prescribed for acute cases, providing relief from swelling and discomfort. In mor...
Read more